Activation of MEK1/2-ERK1/2 signaling during NNK-induced lung carcinogenesis in female A/J mice

Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

(2016) Linda S. Steelman et al.   Aging-US

Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer

(2012) Xiaozhu Zhang et al.   International Journal of Medical Sciences

c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma

(2011) Rafael B. Blasco et al.   CANCER CELL

Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations

(2010) Miyako Hiramatsu et al.   LUNG CANCER

KRASmutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach

(2010) Young-Kwang Yoon et al.   MOLECULAR CARCINOGENESIS

Raf-independent, PP2A-dependent MEK activation in response to ERK silencing

(2009) Dongsoon Bae et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma

(2009) Lee Campbell et al.   CANCER

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer

(2009) Shinobu Hosokawa et al.   LUNG CANCER

Occurrence of mutations in the epidermal growth factor receptor gene in X-ray-induced rat lung tumors

(2008) Tsukasa Kitahashi et al.   CANCER SCIENCE

Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas

(2008) Ana Victoria López-Malpartida et al.   LUNG CANCER